Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alan S Perlman, M.D.
The Rogosin Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Rogosin Institute
New York, New York, United States
Alan S Perlman, MDCholi Hartono, MDDaniel M Levine, PhDDavid Serur, MDJames M Chevalier, MDJohn CL Wang, MDJun Lee, MDLiu M Frank, MDManikkam Suthanthiran, MDMeredith J Aull, PharmDNathaniel Berman, MDNelson Chen, CRCSurya V Seshan, MDThomas S Parker, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2013
- Primary completion
- 31 Aug 2028
- Completion
- 31 Aug 2028
- Last update posted
- 4 Apr 2025
- Registered enrollment
- 2,000
- Registry id
- NCT01802034
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.